Medical Aesthetics Market Share 2021 Global Industry Size, Growth, Demand, Segment, Statistics & Forecast To 2027

Medical Aesthetics Market Overview 

The medical aesthetics market is anticipated to grow by US$23,544.18 by 2025 rapidly growing at a CAGR of 12.97% during the forecast period 2016 to 2025. The global medical aesthetics market is driven by adoption of minimally invasive and non-invasive aesthetic procedures, rising obese and geriatric population, and increasing demand for beauty treatments. An updated review of the medical aesthetics market dynamics, latest developments, and overall industry performance details are presented in the medical aesthetics market study. The research report is based on primary and secondary data. This information is collected from leading organizations, medical aesthetics market stakeholders, company representatives, and key policy makers. The data for the medical aesthetics market report is then analyzed and verified with credible sources. 

Medical Aesthetics Market Segmentation 

The global medical aesthetics market has been segmented based on product, technology, end user. On the basis of technology, the market for medical aesthetics is segmented based on non-invasive, invasive, and minimally invasive. Additionally, the market on the basis of product, is segmented into body contouring devices, facial aesthetic, hair removal devices, cosmetic implants, tattoo removal devices, skin aesthetic devices, and others. The global market for medical aesthetics is also covered based on the end user segment which is further split into dermatology & cosmetic centers, hospitals & clinics, and others. 

Factors like growing demand for aesthetic procedures and rising awareness about hair transplantation and liposuction support the medical aesthetics market growth.The performance of the medical aesthetics market has also been studied for the past and current years. Additionally, the medical aesthetics market report provides detailed analysis of different market segments mentioned above. It also provides analysis of sub-segments to help assist companies active in the global medical aesthetics market. 

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Medical Aesthetics Market Regional Overview 

The medical aesthetics market analysts have segmented the global market into regional markets. The regions covered in the medical aesthetics market report are North America, Asia-Pacific (APAC), Europe, and the rest of the world. In the North American market, many companies functioning in the medical aesthetics market are spread across the United States, Canada, and Mexico. The European market for medical aesthetics has businesses across major European countries including Germany, France, Spain, Italy, and the United Kingdom. Similarly, the global medical aesthetics market is also spread across India, China, and Japan in the Asia-Pacific region. The market report also covers other parts of the world including the Middle East, Africa, among others. 

The global medical aesthetics market report provides comprehensive analysis of regional markets on the basis of medical aesthetics market performance, market size, and revenue. The report also provides growth projections for the medical aesthetics market. 

Medical Aesthetics Market Competitive Landscape 

The global market for medical aesthetics has many growth factors supporting it. But analysts also warn companies to be cautious about the latest market trends covered in the report. The factors which could affect the global medical aesthetics market are also analyzed and are presented in the report. In order to carry out the research, analysts have deeply studied the market and have gathered data from primary and secondary sources. The sources include key healthcare sector stakeholders, policy makers, large corporations, manufacturers, vendors, suppliers, investors, and key decision makers. The data is further analyzed and is presented to derive conclusions about the factors that could support the growth of the medical aesthetics market or negatively affect market growth. 

Medical Aesthetics Industry News 

Aspen Dental Management completed its acquisition of ClearChoice Management Services, empowering the country-wide ClearChoice Dental Implant Centers with robust functional assistance. With over 860 sites in 42 states Aspen Dental is the largest and one of the most successful dental brand networks in the U.S. This is a landmark that puts the two major companies in the dental profession closer.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Genetic Testing Market Latest Innovations, Analysis, Business Opportunities, Component, Industry Revenue And Forecast

Genetic Testing Market Overview

As per the assessment conducted by Market Research Future (MRFR), the global market for the genetic testing market is estimated to garner a market value of USD 22,834.19 million while thriving at a CAGR of 11.50% by 2024. Genetic testing is used in prenatal screening, diagnostics, and as a predictive tool.

The on-going technical development in genetic testing is anticipated to play a significant role in developing the global genetic testing market during the forecast period. The rising demand for genetic testing in oncology and the increasing adoption of genetic tests into clinical care is another salient factor that can drive the regional market. Furthermore, the growing demand for personalized medicine can be recognized a crucial factor that can augment the market size in the assessment timeframe. On the contrary, lack of expertise in developing and underdeveloped countries is expected to hamper the market growth. In addition, the high expenses associated with genetic testing is likely to affect the adoption rate and inhibit the market rise.

The outbreak of COVID-19 is likely to bring a negative impact on the market growth due to the temporary shutdown of testing labs and clinics, which brought a negative impact on the market.

Genetic Testing Market Segmentation

The global market for the genetic testing market can be segmented into method, type, and application.

The method-based segments of the global genetic testing market are molecular genetic tests/ DNA tests, chromosomal genetic tests, and biochemical, genetic tests. Among all, the molecular genetic test/DNA tests is anticipated to procure a market share of 11.78% during the review time.

The type-based segments of the global genetic testing market are prescribed genetic testing and direct to consumer genetic testing. Among all, the prescribed genetic testing is anticipated to procure a major market share while expanding at the highest CAGR by 2024.

The application-based segments of the global genetic testing market are reproductive health, cancer screening, ancestry, predictive and pre-symptomatic testing, and others. Among all, the reproductive health segment is anticipated to lead the segment in the assessment tenure.

Get customized Sample with complete Toc, Inclusive of COVID-19 Industry Analysis @

Genetic Testing Market Regional Analysis

As per the assessment conducted by MRFR, the Americas is anticipated to lead the global market during the forecast period. The region is expected to thrive at the maximum CAGR in the coming time. The increasing demand for personalized genetic testing and the favorable initiatives taken by the government are other salient causes that can grow the market in the coming time. APAC is anticipated to be the fastest-growing region during the review time. The increasing adoption of a sedentary lifestyle and the growing consumption of junk food is likely to play a salient role in driving the regional market in the assessment tenure. Developing countries such as; India and China are anticipated to make a notable contribution in developing the industry in the coming time. On the other hand, MEA is likely to witness the growing adoption of technology and increased government initiatives that can improve the healthcare infrastructure. In addition, the increasing prevalence of metabolic diseases in the region is likely to increase the demand for genetic testing and augment the market share of the region.

Genetic Testing Market Key Players

Some of the renowned players of the global genetic testing market are Blueprint Genetics (Finland), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Myriad Genetics, Inc. (US), Illumina Inc. (US),  QIAGEN N. V.  (Germany), Eurofins Scientific (US), F. Hoffmann-La Roche Ltd (Switzerland), Abbott Laboratories (US), Quest Diagnostics Incorporated (US), BGI Genomics (China), and Thermo Fisher Scientific Inc. (US).

Genetic Testing Industry News

February 2021- Seneca Therapeutics has expanded its R&D pipeline to include six new armed gene therapy/oncolytic constructs directed against important cancer targets and indications.

February 2021– Scientists in Beijing have developed a new gene therapy that can reverse some of the effects of aging in mice and increase their lifespans. The therapy can be fruitful for humans in the future.

February 2021- Taysha Gene Therapies, a patient-centric, clinical-stage gene therapy company, which is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS, announced their collaborations with Cleveland Clinic and UT Southwestern Gene Therapy Program (UTSW_ to advance next-generation mini-gene payloads for AAV gene therapies for the treatment of genetic epilepsies and additional CNS disorders.

February 2021– Paragon Biosciences, a life science innovator, and cell and gene therapy and synthetic biology utilizing AI, has launched CiRC Biosciences, a cell therapy company, developing a treatment for severe diseases with an initial focus on the eye.

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Structural Heart Devices Market Strategic Assessment, Research, Region, Share And Global Expansion

Structural Heart Devices Market Scope 

Market Research Future (MRFR) studied the global structural heart devices market 2021 for the review period till 2023. MRFR findings reveal that the global structural heart device market is expected to surge at 10.4% CAGR in the forecast tenure (from 2018 to 2023). 

Structural Heart Devices Market Drivers and Restrains 

The growing prevalence of non-coronary anomaly of heart interrupting blood supply is creating the need for structural heart devices. The rise in cases of cardiac defects inherited by birth that includes, atrial septal defect, paravalvular leak, ventricular septal defect, patent foramen oval, arterial or venous fistula, and congenital heart disease, is creating the need for advanced structural heart devices. In addition, the inclination of people towards minimally invasive techniques are also boosting sales of structural heart devices. These cause are expected to support the expansion of the structural heart devices market in the study period. The inclination toward advanced products, such as; sutureless heart valve can add to the market rise. On the contrary, expensive sutureless device can limit its the adoption, which in turn, can restrain the market upsurge in the near future. 

Structural Heart Devices Market Segmentation 

The segment assessment of the global structural heart devices market is based on indication, procedure, type, and end-user. 

The type-based segments of the worldwide structural heart device are annuloplasty rings, heart valve devices, occluders accessories, and and delivery systems among other devices. The heart valve devices segment comprises surgical heart valves and transcatheter heart valves. The surgical heart valves segments studies mechanical heart valves and tissue heart valves. The surge in the utility of surgical heart valves can generate decent profit in the coming years. 

The indication-based segments of the structural heart device market are cardiomyopathy, valvular heart disease, and congenital heart defects among others. The valvular heart disease segments studies stenosis and regurgitation. The cardiomyopathy segment is expected to rise at high CAGR in the review period. 

Get Free Sample of This Report at:

The procedure-based segments of the structural heart device market are repair procedures and Replacement Procedures. The Replacement Procedures segment studies SAVR procedures and TAVR procedures. The repair procedures segment study comprises annuloplasty, closure procedures, TMVR procedures, and valvuloplasty. The annuloplasty segment is expected to earn decent revenue for the market. 

The end-users-based segments of the structural heart device market are ambulatory surgery centers, and hospitals among others. The ambulatory surgery centers segment of this market is expected to acquire considerable share of the global structural heart devices market. 

Structural Heart Devices Market Regional Analysis 

In North America, the structural heart devices market is expected to earn decent profit by 2023. The escalating number of cardiac surgeries performed in the region and surge in patients with chronic malaises, such as; high blood pressure, and diabetes among others can contribute to the rise of the regional structural heart devices market in the years to come. The growing awareness about modern healthcare solutions, advancements in technology, surge in disposable income, and medical tourism, are some other factors that can boost the rise of the regional market in the years to come. 

In Europe, the structural heart devices market is likely to hold the second largest share of the worldwide market in the near future. Germany is expected to contribute largely to EU market. The availability of robust healthcare setup for convenience in structural heart devices operations can underpin expansion of the regional market in the years to come. The expansion of elderly group of people and increase in obese in the region can add to the market rise. 

In Asia Pacific, the market of structural heart devices can experience spike in profit. The surge in turnover for the market can be attributed to the increase in the patient population suffering from cardiac issues, alterations in lifestyle, and an increase in elderly people. 

Stringent government policies on healthcare aids and lack of affordable health insurance solutions can can hinder the structural heart device in the Middle East and Afric region. 

Browse Full Report with TOC at:

Structural Heart Devices Market Key Players 

Edwards Lifesciences Corporation (US), Abbott (US), Medtronic plc (Ireland), Boston Scientific Corporation (US), LivaNova plc (UK), Biomerics, ST. Jude Medical, Comed BV, JenaValve Technology, Inc., Endologix Inc. (US)., CardioKinetix, Cook Group Incorporated (US), and W. L. Gore & Associates, Inc. (US) are some top-notch companies in the the global structural heart devices market.

Aromatherapy Market Size, Share, Key Findings, Segmentation, Development Trends And In-Depth Analysis With Specifications

Aromatherapy Market Overview

Aromatherapy has been recognized as an alternative treatment since ages and it is being offered in many healing and therapeutic practices, including yoga studios & spas, massage centers, and even in hospice settings & chiropractic facilities. Using aromatic oils, and other aroma compounds this medical practice helps to heal several health conditions ranging from chronic stress, anxiety, depression, insomnia, trouble sleeping, and muscle pain to respiratory infections, skin problems or disorders, blood sugar fluctuations, and cancer even.

Resultantly, the global aromatherapy market growth is growing pervasively, witnessing augmented uptake as an alternative medicine practice. Factors such as spreading awareness towards aromatherapy’s advantages and easy accessibility to its products cumulatively drive the market growth. Moreover, the development of distribution channels is escalating the market on the global platform, availing various therapeutic-grade aromatherapy products and oils with the convenience of purchasing.

Acknowledging the exponential traction, the market is garnering currently, Market Research Future (MRFR) in its recently published analysis asserts that the already booming, global Aromatherapy market is expected to reach USD 4.3 BN by 2023, registering a CAGR of approximately 6.18 % throughout the forecast period (2017-2023).

Rapid urbanization is further ushering lifestyle-borne disorders such as sleep disturbances, stress, etc. Improving economy, worldwide, on the other hand, is availing the best possible healthcare by enhancing the quality of life of people. The non-invasive nature of aromatherapy is a key factor fostering market growth exclusively. 

On the other hand, factors that are obstructing the market growth include the stringent regulations towards the obligatory differentiation label on the product citing therapeutic grade or cosmetic grade products and the lack of expertise among the therapists. Also, the toxic nature of some of the essential oils like Cineole which is poisonous above the recommended dose and an overdose may cause some severe respiratory symptoms are restricting the market growth.

Also, the lack of solid medical evidence to prove that aromatherapy prevents or cures disorders and diseases mentioned above is impeding the growth of the market up to some extent. 

Get Free Sample of This Report at:

Aromatherapy Market Major Players:

Key players leading the global aromatherapy market include Air Aroma, Nu Skin, Muji, Tree of Life, Zija International, Young Living, dōTERRA, Neal’s Yard Remedies, and NOW Foods among others.

Global Aromatherapy Market   – Segmentations:

For enhanced understanding, the market has been segmented into four key dynamics: 

By Product                                        : Carrier oils & Blended oils, Essential oils (Citrus, Floral, Green/Vegetative, Spicy, and Herbaceous/Camphoraceous, Spices and others), Equipment (Ultrasonic Diffuser, Nebulizer Diffuser, and Heat Diffuser, others), and others.

By Application                                 : Tropical, Inhalation, Aerial Diffusion, and others. 

By Therapeutic Application        : Pain Management, Relaxation & Sleep, Skin & Hair Care, and other remedies. 

By Regions                                        : North America, Asia Pacific, Europe, and the Rest-of-the-World. 

Global Aromatherapy Market – Regional Analysis

The North American region, heading with the extensive adoption in the treatment of various disorders, dominates the global aromatherapy market with the largest share. Moreover, factors such as the high per capita income and healthcare expenditures and the growing applications of aromatherapy in therapeutic applications as well as in cosmetics and personal care products are supporting the growth of the regional market. Canada and the US are major markets for aromatherapy in the region. 

The aromatherapy market in the European region accounts for the second-largest market, globally. France, Italy, and Germany are the major market for aromatherapy products. Moreover, the increasing popularity of aromatherapy as therapeutics and pharmaceuticals is fostering the market growth in the region.  Also, the rising disposable income and the presence of large facilities especially in France and Germany propel the growth of the regional market.

The Asia Pacific aromatherapy market is rapidly emerging as a profitable market, globally. The region is the largest producer of the essential oils, carrier oils, and blended oils which is undoubtedly impacting the market growth in the region, positively. Rapidly developing countries such as China and India have become the largest aromatherapy markets in the region due to the large unmet needs.

The aromatherapy market in the Middle East and African region led by some of the GCC countries such as Saudi Arabia and UAE will witness substantial growth over the forecast period. On the other hand, due to the poor economic and political conditions, the aromatherapy market in the African region will demonstrate a sluggish growth.  

Global Aromatherapy Market – Competitive Analysis

Highly competitive, the aromatherapy market appears to be widely expanded and fragmented characterized by several small and large-scale players. To gain a competitive edge and to sustain their position in the market, these players incorporate various strategic initiatives such as partnership, acquisition, collaboration, expansion, and product launch.

The structure of the market is changing due to the acquisition of local players by multinational companies. Because of the increasing competition in the market, multinational companies are using the strategy of acquisition, which increases the profit of the company while significantly reducing the competition.

Some oil manufacturer practice extraction methods such as steam distillation or solvent extraction to extract essential oils without changing the medication value and nutrients compound of natural herbs and plants that tend to change due to heat. Oils used in aromatherapy are also extracted by the cold press to retain maximum nutrients compound from the natural plants or herbs.

Key players are focusing more on the expansion of aromatherapy business across the globe which is contributing around 40% increase in the market share. After expansion, these players are acquiring promising companies to strengthen their presence and to get an edge over the increasing competition in the market.

Browse Full Report with TOC at:

Aromatherapy Industry/innovation/Related News:

March 04, 2019 –– Subtle Energies (Australia), leading global aromatherapy, natural skin care, and wellness solutions brand announced that the hotel Peninsula Chicago has strengthened their long partnership by exclusively offering Subtle’s line of Ayurveda-informed techniques and treatments at The Peninsula Spa.

Aromatherapy Market 2027 Insights Analysis and Company Profiles

Aromatherapy Market Overview

Aromatherapy is the usage of volatile liquid plant materials and various other aroma compounds extracted from plants that is used to affect the mood and health of individuals. It is generally associated with complementary and alternative medicine (CAM). The aromatic oils coupled with the aroma compounds of plants help improve the psychological and physical well-being of individuals. The latest in-depth research conducted by the team of Market Research Future, reveals a positive growth phase for the aromatherapy market with an expected reach of $4.3 billion by the end of 2023 and a projected CAGR of 6.18% during the review period of 2017-2023.

The research also identifies the various factors and constraints that are supporting or pulling down the market growth of aromatherapy. The global aromatherapy market size is influenced by key factors such as the large percentage of population opting for aromatherapy measures, the non-invasive nature of aromatherapy, the burgeoning lifestyle industry, and other factors. The modern-day lifestyle has brought forward problems such as stress, anxiety, sleep disturbances, etc. that have inflated the market. Moreover, various essential oils (EO) help increase the immunity level, fight against cold and breathing disorders.

Some of the market constraints include the increasing stringency of regulations like indications that a market player needs to provide. For instance, market players have the task cut out to mention whether the particular essential oil comes under cosmetic grade or therapeutic grade.  Also, the lack of precise guidelines and the toxic nature of essential oils is another big hindrance to the sector. Furthermore, there is little to no medical evidence concerning how effective aromatherapy is in preventing or curing diseases.

Aromatherapy Market Competitive Analysis

The global aromatherapy market includes various key players that are consistently coming up with new and innovative additions to the market. Some of the key players herein include Young Living (USA), Neal’s Yard Remedies (United Kingdom), Tree of Life (made by Jaroma), dōTERRA (USA), Muji (Japan), Nu Skin (USA), Air Aroma (USA), NOW Foods (USA), and Zija International (China).

Aromatherapy Market Segmentation

The global Aromatherapy market is segmented on the following basis: product, equipment, application, and therapeutic application.

By product: The market includes therapeutic application, equipment, application, and essential oils. Essentials oils are further narrowed down into citrus, green/vegetative, floral, spicy, herbaceous/camphoraceous, and others.

By equipment: The market includes ultrasonic diffuser, nebulizer diffuser, and heat diffuser.

By application: The market comprises inhalation, tropical, and aerial diffusion.

By therapeutic application: The market includes pain management, relaxation, skin and hair care, and other remedies.

Aromatherapy Market Regional Analysis

The regional market segmentation of the global aromatherapy market includes North America, Asia-Pacific, Europe, and Middle East & Africa (MEA).

The North American region holds the largest share of the global Aromatherapy market with the US being the most prominent nation contributing to the region’s growth. The dominance of the US region is due to the high per capita disposable income and increasing expenditure on the healthcare sector. Europe stands tall as the second largest market owing the presence of big hospitals and large disposable income. The market in Europe is spearheaded by France, followed by Germany.

The Asia-Pacific region is slated to the fastest growing region owing to the large unmet needs that is led by economic powerhouses like China and India. The Middle Eastern market will be led by countries like Saudi Arabia and UAE. Whereas, in Africa the region is expected to experience little to no growth owing to the poor economic and political situation.

Get full report & TOC @:

Aromatherapy Industry News

On January 2019, a new smart gadget named AROM was launched for the purpose of aromatherapy and scent layering. The gadget boasts the ability to mix and match your own personalized scents and one can even share the same via mobile application, AROM is said to be the next generation of aromatherapy and scent layering.

On January 2019, Major Brands, one of the premier retailers in India, launched the first ever Bath & Body Works store in Mumbai. The latter is regarded as one of the biggest and the most sought-after personal essentials and fragrance brands worldwide. The move will further expand the market for skin care products in India.

Structural Heart Devices Market: 2021 Global Sales, Size, Share, Competitive Analysis, Upcoming Opportunities And Forecast To 2027

Structural Heart Devices Market Overview: 

The global market report on the structural heart devices is on a path to score a CAGR of 10.4% during the forecast period of 2018 to 2023. Market Research Future (MRFR), in its report, dealt with several factors and restraints to understand the market flow.  

Factors included in the market report are the hike in investment for the research and development facilities, better inclusion of advanced technologies, and rising demand for minimally-invasive surgeries. Various private and public organizations are ensuring the maintenance of a proper line of investment flow during the forecast period. A surge in demand for minimally-invasive surgeries is providing scope for the incorporation of advanced technologies. In developing regions, growing development in the healthcare facilities is going to attract better investment and ensure a hike in market revenues.  

However, the high cost of products can be a restraint for the global structural heart devices market. In addition, stringent government policies can deter growth.  

Structural Heart Devices Market Competitive Landscape: 

There are several structural heart device companies that are impacting the market by launching new structural heart disease devices and implementing other strategies that include mergers, acquisitions, collaborations, spurring the investment in the research and development sector, and others. These companies are Medtronic plc (Ireland), Edwards Lifesciences Corporation (US), LivaNova plc (UK), Abbott (US), Boston Scientific Corporation (US), ST. Jude Medical, Biomerics, Comed BV, JenaValve Technology, Inc., Endologix Inc. (US)., Cook Group Incorporated (US), CardioKinetix, and W. L. Gore & Associates, Inc. (US). MRFR’s analysis of the market focuses on the recent developments made by these companies that will give know-how of how the companies are trying to perform in the coming days. This will also boost the strategy making policies.  

Structural Heart Devices Market Segmentation: 

MRFR analysts have segmented the global structural heart devices market into type, indication, procedure, and end-user to allow a better understanding of the market.  

By type, the global market study includes segments like occluders and delivery systems, annuloplasty rings, accessories, heart valve devices, and other devices. The heart valve devices include transcatheter heart valves and surgical heart valves. The segment of surgical heart valves comprises tissue heart valves and mechanical heart valves. 

By indication, the market study covers segments like cardiomyopathy, congenital heart defects, valvular heart disease, and others. Valvular heart disease includes regurgitation and stenosis. 

By procedure, the market report comprises segments like Replacement Procedures and repair procedures. The segment of Replacement Procedures includes TAVR procedures and SAVR procedures. The repair procedures are known for their segments like closure procedures, valvuloplasty, annuloplasty, and TMVR procedures. 

By end-users, the market report on the structural heart devices market includes ambulatory surgery centers, hospitals, and others. 

Structural Heart Devices Market Regional Analysis: 

North America would lead the global market for its easy incorporation of structural heart medical devices in the medical sector. High investment capacity can also boost the regional market growth. The Asia Pacific region would gain from growing investment in the healthcare sector and market expansion plans of the top plaayers who find the region as a profit-making opportunity. 

Browse Full Report with TOC at:

Structural Heart Devices Industry News: 

In March 2020, Keystone Heart Ltd., a part of the Venus Medtech Company, declared that its TriGUARD 3 Cerebral Embolic Protection (CEP) Device products received European CE Mark. The device can be used to minimalize the impact of cerebral damage. The machine follows a path where it deflects the embolic debris away from cerebral circulation while the Transcatheter Aortic Valve Implantation (TAVI) and other transcatheter heart procedures are on. This will boost the global structural heart devices market. 

Endoscopy Device Market Overview, Global Size, Business Opportunities, Growth, Segments, Industry Profits And Trends By Forecast To 2027

Endoscopy Device Market Competitive Landscape

RICHARD WOLF, Micro-Tech Endoscopy, Cognetix, Stryker, PENTAX MEDICAL, Interscope Inc., Cogentix Medical, KARL STORZ Gmbh & Co. KG, OLYMPUS, J&J services Inc., Cantel Medical, Shaili Endoscopy, FUJIFILM, and Integrate Endoscopy are the key players in the global endoscopy device market. 

Endoscopy Device Market Overview

An endoscope is a specialized instrument intended for performing endoscopy, a procedure that allows diagnosis of interior parts of organs. They are used for both therapeutic and diagnostic purposes. Endoscopic procedures are used to treat and identify medical conditions such as non-cancerous polyp, gastric cancer, bile duct stones, and Barrett’s esophagus. The global endoscopy devices market size is anticipated to exhibit a CAGR of 6.3% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an exhaustive study.

Endoscopy devices have become the first line of treatment in case of major infections and diseases. The growing popularity of minimally invasive medical procedures coupled with the prevalence of chronic diseases have generated high demand for endoscopy procedures and subsequently driven the global endoscopy device market.

Technological advancements in endoscopy devices have led to the development of improved endoscopy devices with reduced scope size, and other improvements which allow rotation and steering, ultra-high definition, and advanced imaging modalities which have further increased adoption of endoscopy devices among healthcare professionals.

Medical device manufacturers are outlaying massive amounts on R&D activities for the development of more innovative and minimally invasive endoscopy devices. Innovation in terms of hardware and software technologies in endoscopes have further opened a new era in endoscopic diagnosis. New product development and rise in the number of FDA approvals have also reflected positively on the growth of the global endoscopy devices market.

Improvement in reimbursement scenario for endoscopic procedures, expansion of healthcare expenditure, and rise in the number of hospitals, diagnostic centers with state-of-the-art facilities are other factors fostering the growth of the global endoscopy device market.

On the downside, risks of infection, piercing or a tear in the organ being treated, and bleeding are possible bottlenecks to the global endoscopy device market. 

Endoscopy Device Market Segmentation

The global endoscopy device market has been segmented based on type, therapy, treatment & procedure, application, accessory & processor, and end user.

By type, the global endoscopy device market has been segmented into flexible endoscopes, rigid endoscopes, surgical endoscopes, robot-assisted endoscopes, and capsule endoscopes.

By therapy, the global endoscopy device market has been segmented into colonoscopy, gastroscopy, sigmoidoscopy, endoscopic retrograde cholangiopancreatography, arthroscopy, laparoscopy, ureteroscopy, and cystoscopy.

By treatment &bprocedure, the global endoscopy device market has been segmented into lower gastrointestinal conditions, abdominal, gynecologic and pelvic organ conditions, lung and airway conditions, joint and orthopedic conditions, upper gastrointestinal conditions, and urinary system conditions.

The Abdominal, gynecological, and pelvic organ conditions segment has been further segmented into hernia repair, removal of the appendix, gallbladder, spleen, uterine fibroids, endometrial tissue, and ectopic pregnancy.

The Joint and orthopedic conditions segment has been further segmented into carpal tunnel syndrome, torn or damaged cartilage, tendons, arthritis, repair of rotator cuff conditions, and loose bone or cartilage.

The lower gastrointestinal conditions segment has been further segmented into removal of colon polyps, and treatment of bleeding from the colon.

The lung and airway conditions segment has been further segmented into lung abscess, removal of a foreign object in the airway, and opening of a narrowed airway.

The Upper gastrointestinal conditions segment has been further segmented into removal of polyps and foreign objects, treatment of hypertensive lower esophageal sphincter, widening of a narrowed esophagus, Barrett’s esophagus, and esophageal cancer.

The urinary system conditions segment has been further segmented into kidney stones.

By application, the global endoscopy device market has been segmented into gastrointestinal endoscopy, obstetrics/gynecology endoscopy, bronchoscopy, arthroscopy, urology endoscopy, mediastinoscopy, and otoscopy.

By accessory & processor, the global endoscopy device market has been segmented into accessory and processors.

By technology, the global endoscopy device market has been segmented into video and fiber.

By end user, the global endoscopy device market has been segmented into critical care, gastroenterologists, general and pediatric surgeons, obstetricians-gynecologists (ob/gyns), and orthopedic surgeons. 

Endoscopy Device Market Regional Analysis

By region, the global endoscopy devices market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).

The Americas is leading the global endoscopy device market due to the presence of robust healthcare infrastructure, massive development within the healthcare sector and high healthcare expenditure in the region. The Americas market is expected to reach a valuation of USD 15,186.1 Mn by 2023.

Europe accounts for the second largest share of the global endoscopy device market. Growing emphasis on the diagnosis and treatment of cancer and other gastrointestinal diseases.

APAC market for endoscopy device is likely to showcase rapid growth over the forecast period. Massive unmet medical needs due to the prevalence of chronic diseases in the region present ample growth opportunities to the market. Expanding healthcare budget in emerging economies also act as a plus for the growth of the market.

The MEA market will be led by Gulf nations such as Qatar and Kuwait who are investing heavily on the development of the healthcare sector. 

Get Premium Research Report, Inclusive of COVID-19 Impact Analysis, Find more information @

Endoscopy Device Industry Updates

In February 2019, OmniVision Technologies, Inc., a leader in advanced digital imaging solutions and Lighthouse Imaging, a medical contract manufacturer jointly announced the launch of a platform which is capable of integrating stereoscopic 3D imaging into endoscopes. The new platform is equipped with two CMOS image sensors and an image signal processor (ISP) from OmniVision, and camera control unit from Lighthouse. The new platform overcomes the complexity, size and cost constraints associated with the 3D endoscopy. 

Patient Monitoring Devices Market 2021 | Industry Analysis, In-Depth Analysis, Research, Growth, Latest Innovations, Revenue, Forecasts To 2027

Patient Monitoring Devices Market Overview:

The global report describing the details of the patient monitoring devices market reveals substantial possibilities for the market to achieve an impressive growth during the forecast period of 2016 to 2022. Market Research Future (MRFR) revealed various factors that can secure the growth path for the market. These are demand for better patient care, high inclusion of top-class technologies, increasing competition among various market players, hike in investment for research and delivery, and others. The global market would gain more from the recent changes made by the FDA in their monitoring policies. The digital patient monitoring devices market is expecting better boost.

Patient Monitoring Devices Market Segmentation:

The global market for patient monitoring devices market size is segmented in the report published by MRFR on the basis of product type and end users. These segments are rich with analyses of various market factors that can impact the market in the coming years. Gathered data from such reviews are expected to boost the tactical understanding of the market.

By product type, the global market report on the patient monitoring devices has been segmented into Portable bedside monitors, Temperature monitoring devices, Electrocardiogram (ECG) Devices, Hemodynamic Monitoring Devices, Central monitoring stations, Respiratory Monitors, Weight management monitors, Fetal and neonatal monitors, and others.

By end user, the market report on the patient monitoring devices can be segmented into Ambulatory care centers, hospitals and clinics, Home care, and others. The hospitals and clinics segment is predicted to boost the global market for better facilities and increased investment in the healthcare sector. Recent advancements in the technology is also providing thrust to the home care sector.

Patient Monitoring Devices Market Regional Analysis:

North America is slated to boost the global market for the patient monitoring devices market with high expenditure for the healthcare sector. The region is expected to get boosted by better technological inclusion and various reimbursement policies. The US and Canada are major countries in the region with top-class infrastructural benefits that is helping the growth. Remote patient monitoring statistics are showing better inclusion rate. 

In Europe, similar trajectories will be followed by countries like the UK, France, Germany, Italy, Switzerland, and others. In the Asia Pacific region, revamping of the healthcare sector in developing regions can support the regional market growth. India, China, Japan, South Korea, and others are registering notable progress.

Patient Monitoring Devices Market Competitive Landscape:

The global market for patient monitoring devices is getting ample traction from several sectors like Roche Diagnostics, GE Healthcare, KG, Abbott Laboratories, Siemens Healthcare, BIOTRONIK SE & Co. CAS Medical Systems, Inc., Philips Healthcare, Honeywell International, Inc., Spacelabs Healthcare, and Shenzhen Mindray Bio-Medical Electronics Co. Relying on strategic moves like mergers, acquisitions, collaborations, rising investment in the research and development sector, innovations, better technological inclusions, and others, these companies are expanding their market operations. Patient monitoring companies and market share have been mentioned in the report as well.

Browse Full Report with TOC at:

Patient Monitoring Devices Industry News:

The recent attack of COVID-19 pandemic has forced a lot of hospitals to rely on their patient monitoring management system from far. This is to ensure more beds for the Covid-19 patients. This is also getting backed by FDA who are now launching special regulations to maintain a proper workflow.

In April 2020, GE Healthcare launched their new Mural Virtual Care Solution to provide assistance to doctors and nurses in taking proper care of their patients. This system is getting boost from a very efficient Microsoft Azure cloud platform. The system will help in effective handling of the clinical surveillance of intensive care unit (ICU) patients. It can also manage the mechanical ventilators that are mandatory in managing the COVID-19 patients. This endeavor is to reduce the chances of exposure to COVID-19 patients and contraction of the disease.

Chronic Disease Management Market To 2027: Top 10 Companies, Trends, Growth Factors And Forecast

Chronic Disease Management Market Overview

Global chronic disease management market is expected to grow at a CAGR of 17.5% over the forecast period from 2017 to 2023, according to a new research report from Market Research Future (MRFR). The global chronic disease management market is mainly driven by the growing prevalence of chronic diseases and the increasing realization of the need for specialized, dedicated chronic disease management solutions.

Chronic disease management includes monitoring a patient with chronic diseases and bringing all aspects of their lifestyle in line with the desired effect of the medication. Such facilities are usually established by hospitals looking to expand into more dedicated care for chronic diseases. The growing prevalence of chronic diseases around the world has been the major driver for the global chronic disease management market in recent years. Chronic diseases such as cancer and diabetes are rising in prevalence continuously, leading to a need for dedicated facilities. Close to 1.7 million new cases of cancer were registered in the U.S. in 2016, whereas diabetes is estimated to have claimed more than 420 million adult patients around the world. The growing prevalence of these diseases is likely to drive the global chronic disease management market over the forecast period.

Several chronic diseases require patients to adhere to a certain lifestyle for easy and quick recovery. Adhering to this lifestyle can be difficult in one’s own home, as one may forget certain aspects. Such conditions are avoided in chronic disease management, as a physician keeps track of the lifestyles of the patients, allowing them to keep up with the required activities and prohibitions through the rehabilitation period.

On the other hand, the high prices of chronic disease management could emerge as a blow to the global chronic disease management market’s prospects over the forecast period. However, the increasing government support for chronic disease management centers has the potential to overcome this barrier in the coming years.

Chronic Disease Management Market Competitive Analysis:

Leading players in the global chronic disease management market include TriZetto Corporation, Pegasystems Inc., Wellcentive Inc., i2i Systems Inc., Allscripts Healthcare Solutions Inc., Epic Corporation Inc., Infosys Limited, Harmony Information Systems Inc., ZeOmega Inc., HealthSmart Holdings Inc., Medecision Inc., AxisPoint Health, and Phytel Inc.

In April 2019, University Hospitals Geauga launched a new chronic disease management clinic. Such moves are aimed primarily at the geriatric demographic, which may find it difficult to remember particular aspects of the lifestyle to be followed.

Chronic Disease Management Market Segmentation:

The global chronic disease management market is segmented on the basis of service types, application, deployment, end user, and region.

On the basis of the service type, the chronic disease management market is segmented into consulting services, implementation services, educational services, and others.  

On the basis of the application, the chronic disease management market is segmented into asthma, cancer, cardiovascular, diabetes, stroke, and others.  

On the basis of deployment, the market is segmented into on-premise, web-based, and cloud-based.

On the basis of end user, the market is segmented into provider and payer.

Browse Complete Report with TOC at

Chronic Disease Management Market Regional Analysis:

North America, followed by Europe, is the leading regional market for chronic disease management and is likely to retain the position over the forecast period. The high level of technological innovation in North America and the increasing government expenditure on healthcare have allowed for the development of a number of effective chronic disease management facilities. The widespread prevalence of a number of chronic diseases in North America is also a major driver for the chronic disease management market in the region. Diseases such as cancer and diabetes are widely prevalent in North America, helped along by unhealthy lifestyle factors such as excessive smoking and excessive sugar consumption.

Asia Pacific is the fastest growing regional market for chronic disease management. Due to the relatively advanced and specialized nature of chronic disease management, only a small number of facilities have been established in Asia Pacific so far, with Japan taking up the lion’s share in the region’s chronic disease management market.

Wearable Medical Device Market Analysis, Future Plans, Technological Advancement, Growth Prospects Predicted By 2027

Wearable medical devices are electronic devices capable of measuring various metrics on the human body without doctor intervention. They have attracted mainstream attention via smartwatches. Insurance companies and healthcare organizations are pondering the benefits of wearables to patients in the long run. The global wearable medical device market report by Market Research Future (MRFR) highlights the developments around the technology and applications in the medical sector as well as several factors and challenges to be faced by key market leaders for the period of 2017 to 2023 (forecast period).

Wearable Medical Device Market Scope

The global wearable medical device market is forecasted to be valued at USD 27,255.6 million by 2023. It was valued at USD 7,859.4 million in 2017.

The developed countries, in particular, are frontrunners in the adoption of advanced technology solutions and continuous innovation in these technologies can influence the market demand. These devices have demonstrated efficacy in the management of chronic diseases of diabetes, asthma, and heart diseases, the occurrence of which is soaring across the globe. Wearable medical devices have gained significant traction in monitoring various health parameters such as heart rate, blood oxygen level, body fat, and respiration. Patient awareness pertaining to healthcare devices and the high healthcare expenditure across developed countries can bolster the market growth. Rise of lifestyle diseases, cost-effectiveness of devices, and the connected healthcare ecosystem are factors predicted to spur the demand of wearables.

On the contrary, the low adoption and awareness rate of wearable medical devices in underdeveloped regions of the world, partly because of low healthcare penetration and poor economic conditions can hamper the market growth. In addition, concerns relating to privacy and cybercrime can also pose a challenge to the global wearables medical and health market.

Wearable Medical Device Market Segmentation

The market has been assessed under type, device type, application, and distribution channel. By type, wearable medical devices such as smart clothing, activity monitors, smart watches, and patches were considered for market sizing. The scope of the discussion also covers therapeutic devices and diagnostic & monitoring devices. The report also highlights key application areas of wearable medical devices, which include remote patient monitoring, sports academies and fitness, and home healthcare. The wearable medical device market major distribution channels for wearable medical devices discussed in the report include pharmacies, hypermarkets, and online channel.

Wearable Medical Device Market Regional Analysis

The Americas, the Middle East & Africa (MEA), Asia Pacific (APAC), and Europe are major regions covered in the global hemifacial spasm market report.

The Americas dominate the global wearable medical devices market on account of the increasing cases of obese and diabetic population in the region and the need to monitor their metrics closely. Moreover, the penetration of smart medical devices in the region made possible by the need for affordable healthcare can drive the North America wearable medical device market.

Europe is the second most significant market for wearable medical devices. Increasing health awareness, the prevalence of chronic diseases and high healthcare expenditure are factors fostering the growth of the Europe wearables medical and health market.

The APAC market is expanding rapidly and is driven by a booming population, increasing healthcare expenditure and growing penetration of smart wearable devices in the region, especially in the emerging economies of the region.

Browse Full Report with TOC at:

Wearable Medical Device Market Competitive Outlook

Fitbit Inc., Motorola Solutions Inc., LG Electronics Inc., Honeywell International Inc., Medtronic PLC, Qualcomm Inc., Sony Corporation, NIKE INC., Omron Corporation, Philips, Apple Inc., and Boston Scientific Corporation are prominent players of the global wearable medical device market.

Wearable Medical Device Industry News

Alpha-Stim, the wearable electrotherapy device by Electromedical Products International, has been approved by the U.S. FDA for alleviating anxiety, depression, and chronic & acute pain without side-effects.

Create your website with
Get started